GeriPal

DECEMBER 15, 2022

Summary Transcript Summary. We’ve talked at length on prior podcasts about the failures of aducnumab, Biogen, and the FDA’s decision to approve it. . But wait, there’s a shiny new anti-amyloid drug, lecanemab! (No No it’s not just the French version of Aducanumab). . In an article in the NEJM (a published article this time, wonder of wonders!)

IT 105

IT Patient-Centered Healthcare Illness 105

GeriPal

DECEMBER 8, 2022

Eric’s blog post on Dignity Therapy from 2011. Summary Transcript Summary. Eric and I weren’t sure what to call this podcast – storytelling and medicine? Narrative medicine? We discussed it with today’s guests Heather Coats, palliative care NP-scientist, and Thor Ringler, poet. Because that really is what this is about. SPONSOR: .

Patient-Centered 115

Patient-Centered Illness Healthcare IT 115

FDA Law Blog

MAY 26, 2025

Second, the memo makes it clear that the intended investigation targets are persons and entities providing medical care, but the statutes own definition of FGM excludes such care. FGM is defined as any procedure performed for non-medical reasons. Late last month the Attorney General issued a memo addressing both directives.

Manufacturing 59

Manufacturing Provider Medical IT 59